ARID4B Promotes the Progression of Hepatocellular Carcinoma Through the PI3K/AKT Pathway
Munetoshi Akaoka(Jikei University School of Medicine), Toru Ikegami(Jikei University School of Medicine), Ryoga Hamura(Jikei University School of Medicine), Tomohiko Taniai(Jikei University School of Medicine), Koichiro Haruki(Jikei University School of Medicine), Michinori Matsumoto(Jikei University School of Medicine), Kenei Furukawa(Jikei University School of Medicine), Shinji Onda(The Jikei University Hospital), Masayuki Shimoda(Jikei University School of Medicine), Mitsuru Yanagaki(Jikei University School of Medicine), Hoshiho Kubota(Jikei University School of Medicine), Yoshihiro Shirai(Jikei University School of Medicine), Masashi Tsunematsu(Jikei University School of Medicine)
Cited by 5
Related Papers
Negative Impact of Blood Transfusion on Recurrence and Prognosis of Hepatocellular Carcinoma After Hepatic Resection
|Journal of Gastrointestinal Surgery|2009|95
Utility of augmented reality system in hepatobiliary surgery
|Journal of Hepato-Biliary-Pancreatic Sciences|2012|47
Impact of C-reactive protein–albumin–lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis
|Surgical Oncology|2023|46
High-Throughput Functional Evaluation of <i>MAP2K1</i> Variants in Cancer
|Molecular Cancer Therapeutics|2022|32